Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
248.50    3.50 (1.43%)
Bid:
249.00
Ask:
251.00
Spread: 2.00 (0.803%)
Market Cap: £144.97m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Board Changes

30 Apr 2007 14:34

Gleeson(M J)Group PLC30 April 2007 Monday 30 April 2007 MJ GLEESON GROUP PLC Board Changes Gleeson (GLE.L), which is transforming itself into a specialist in housingregeneration, announces the appointment of a Group Finance Director and theresignation of an Interim Executive Director. Appointment of Group Finance Director Gleeson is pleased to announce the appointment as Group Finance Director ofChris Holt, who since August 2006 has been the Interim Group Finance Director.The appointment follows a competitive selection process involving externalconsultants and is effective 1 May 2007. Nicholas Christopher Holt, BSc, MBA, CIMA, aged 55, has obtained widespreadfinancial experience over 30 years with internationally renowned businesses,namely Foster Wheeler (1987-2005), Bechtel (1975-87) and British Oxygen(1972-75). At Foster Wheeler, the global engineering and construction contractor and powerequipment supplier, Chris was most recently Chief Financial Officer of itsEuropean Power business based in Helsinki, Finland, with c €400m turnover and1,700 employees based in Finland, Germany, Poland, Sweden, Spain and Thailand.Previously, Chris was Group Finance Director and Deputy Chairman of FosterWheeler UK Ltd, a £ 500m turnover business, with c3,000 employees. His 12 yearsat Bechtel, one of the world's premier engineering, construction and projectmanagement companies, had culminated in two years as Finance Director, Oil &Gas, for the EMEA region. Dermot Gleeson, Chairman, stated "Chris joined us in May 2006 to help out withthe complex matter of the disposal of Gleeson's Engineering Division, which wassuccessfully achieved in October 2006. He was soon providing invaluable supportto our Group Chief Executive, Paul Wallwork, in the implementation of Gleeson'swider programme of strategic change. Chris' extensive experience with topcompanies and his track record with Gleeson to date, dealing with both areas offuture focus and legacy businesses, qualify him admirably to assume a permanentrole." Chris Holt has held no directorship in any other publicly quoted company at anytime in the previous five years and there are no details to be disclosed underparagraph 9.6.13 R of the Listing Rules. Resignation of an Interim Executive Director Gleeson announces the resignation as Interim Executive Director of Edwin Lawrie,ACII, FIRM, ACIS, who has held that position since August 2006, during whichtime Paul Wallwork has been the Company's only non-Interim Executive Director.Mr Lawrie continues as Company Secretary, with the Board's thanks for hisstanding in as an Executive Director. Photographs: Photographs of Chris Holt are available from Charles Ponsonby of BanksideConsultants at charles.ponsonby@bankside.com Enquiries: M J Gleeson Group plc 01252-360 300Paul Wallwork (GCEO)Chris Holt (GFD) Bankside ConsultantsCharles Ponsonby 020-7367 8851 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
12th Feb 20254:14 pmRNSDirector/PDMR Shareholding
11th Feb 20257:00 amRNSResults for the half year ended 31 December 2024
7th Feb 202511:51 amRNSDirector/PDMR Shareholding
14th Jan 20257:00 amRNSTrading Update & Notice of Results
7th Jan 20254:28 pmRNSDirector/PDMR Shareholding
9th Dec 20244:59 pmRNSDirector/PDMR Shareholding
3rd Dec 20243:50 pmRNSDirector/PDMR Shareholding
26th Nov 20243:34 pmRNSDirector/PDMR Shareholding
15th Nov 20242:08 pmRNSResult of AGM
15th Nov 20247:00 amRNSAGM Trading Update
7th Nov 20242:44 pmRNSDirector/PDMR Shareholding
30th Oct 202410:42 amRNSDirector/PDMR Shareholding
21st Oct 20247:00 amRNSNotice of AGM
18th Oct 20244:24 pmRNSDirector/PDMR Shareholding
18th Oct 20244:19 pmRNSDirector/PDMR Shareholding
9th Oct 20244:27 pmRNSDirector/PDMR Shareholding
4th Oct 202410:18 amRNSDirector/PDMR Shareholding
30th Sep 20247:00 amRNSTotal Voting Rights
18th Sep 20247:00 amRNSAudited results for the year ended 30 June 2024
9th Sep 202410:18 amRNSDirector/PDMR Shareholding
30th Aug 20247:00 amRNSTotal Voting Rights
7th Aug 20249:41 amRNSDirector/PDMR Shareholding
31st Jul 20247:00 amRNSTotal Voting Rights
23rd Jul 20242:36 pmRNSDirector/PDMR Shareholding
23rd Jul 20241:53 pmRNSStandard form for notification of major holdings
11th Jul 20247:00 amRNSFY2024 Trading Update
8th Jul 20241:34 pmRNSDirector/PDMR Shareholding
8th Jul 20247:00 amRNSNotice of Trading Update
28th Jun 20247:00 amRNSTotal Voting Rights
6th Jun 20242:46 pmRNSDirector/PDMR Shareholding
31st May 20247:00 amRNSTotal Voting Rights
15th May 20247:00 amRNSAppointment of Joint Corporate Broker
9th May 20249:41 amRNSDirector/PDMR Shareholding
30th Apr 20247:00 amRNSTotal Voting Rights
8th Apr 20243:41 pmRNSDirector/PDMR Shareholding
3rd Apr 20244:28 pmRNSDirector/PDMR Shareholding
2nd Apr 20243:28 pmRNSDirector/PDMR Shareholding
28th Mar 20247:00 amRNSTotal Voting Rights
22nd Mar 20249:07 amRNSDirector/PDMR Shareholding
20th Mar 20241:45 pmRNSDirector/PDMR Shareholding
29th Feb 20247:00 amRNSTotal Voting Rights
26th Feb 20241:04 pmRNSDirector/PDMR Shareholding
15th Feb 20247:00 amRNSResults for the half year ended 31 December 2023
7th Feb 202411:34 amRNSDirector/PDMR Shareholding
31st Jan 20247:00 amRNSTotal Voting Rights
9th Jan 202410:50 amRNSDirector/PDMR Shareholding
9th Jan 20247:00 amRNSTrading Update & Notice of Results
29th Dec 20237:00 amRNSTotal Voting Rights
15th Dec 20232:49 pmRNSRe Directorate External Appointments
6th Dec 20234:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.